Moses Im

CEO of Fairway Health. Moses was previously an MD candidate at Thomas Jefferson Medical School where he also was a clinical researcher in patient outcomes of surgical vs transcatheter aortic valve replacement. Before medical school, he also did molecular biology research at Princeton University in HIF-1α as a possible therapeutic target for Parkinson's Disease and the role of HIF-1α in early-stage development of aviary lungs. Moses has a bachelor’s degree in molecular biology from Princeton.